Subjects must be co-enrolled in protocol 03-C-0277
Subjects must be co-enrolled in 03-C-0277
Subject’s must be co-enrolled in protocol 03-C-0277
Subjects must be co-enrolled in protocol 03-C-0277
Subjects must be co-enrolled in protocol 03-C-0277
Subjects must be co-enrolled in protocol 03-C-0277
Subjects must be co-enrolled on protocol 03-C-0277
Subjects must be co-enrolled in protocol 03-C-0277
Subjects must be co-enrolled in protocol 03-C-0277
Subjects must be co-enrolled in protocol 03-C-0277
Enrolled in another treatment protocol
Subjects must be co-enrolled in protocol 03-C-0277
Subjects must be co-enrolled in protocol 03-C-0277
Subject must be co-enrolled in protocol 03-C-0277
Subjects must be co-enrolled on protocol 03-C-0277
Male or female subjects of the age defined in the original protocol they were enrolled.
Subjects will not be treated with any radiation, chemotherapy, or investigational agents while enrolled in this protocol.
Participants enrolled in a radiation de-intensification protocol
Previously enrolled patients who completed this protocol
FOR THE 31 SUBJECTS ENROLLED IN YEAR 1: Pregnant female
Subjects may be enrolled at any point in diagnosis or treatment
Subject enrolled into the protocol BDS-USHPV and identified as eligible for the longitudinal protocol • Subjects enrolled into protocol BDS-USHPV with a baseline colposcopy and biopsy procedure and not treated.
Patient must be enrolled or being considered for enrollment on protocol 2010-0085
